Finance

Beta
Lists
IKPM:IDX
Ikapharmindo Putramas Tbk PT
IDR 195.00
0.00%
(0.00) 1D
Jun 4, 4:00:05 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for IKPM...
Mkt. cap
328.51B
Avg. vol.
757.17K
Volume
0.00
52-wk high
IDR 340
52-wk low
IDR 173
EPS
-IDR 16
Shares outstanding
1.68B
No. of employees
1K
Mkt. cap
328.51B
Avg. vol.
757.17K
Volume
0.00
52-wk high
IDR 340
52-wk low
IDR 173
EPS
-IDR 16
Shares outstanding
1.68B
No. of employees
1K
News stories
From sources across the web
About Ikapharmindo Putramas Tbk PT
CEO-
Employees1.03K
Founded1978
Headquarters-
SectorPersonal care products
Websiteikapharmindo.com
Previous reportsAll values in IDR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in IDR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
85.14B
81.65B
106.47B
103.84B
Cost of goods sold
48.09B
51.94B
63.51B
56.37B
Cost of revenue
48.09B
51.94B
63.51B
56.37B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
41.97B
48.83B
45.09B
45.58B
Operating expense
41.25B
50.15B
44.06B
44.27B
Total operating expenses
89.34B
102.09B
107.56B
100.64B
Operating income
-4.20B
-20.43B
-1.10B
3.20B
Other non operating income
-
-
-
-
EBT including unusual items
-7.72B
-22.81B
-3.54B
877.41M
EBT excluding unusual items
-7.53B
-23.22B
-3.71B
739.28M
Income tax expense
-
-
-6.71B
-
Effective tax rate
-
-
189.49%
-
Other operating expenses
-727.48M
1.32B
-1.03B
-1.30B
Net income
-7.72B
-22.81B
3.17B
877.41M
Net profit margin
-9.07%
-27.94%
2.98%
0.84%
Earnings per share
-
-
-
-
Interest and investment income
4.60M
17.63M
44.03M
88.93M
Interest expense
-3.28B
-3.16B
-2.98B
-3.03B
Net interest expenses
-3.28B
-3.14B
-2.94B
-2.94B
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.36B
-18.41B
852.14M
5.13B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer